A R T I C L E S
Watson and Yudin
MHz): δ 196.6, 137.3, 137.2, 135.4, 133.2, 128.7, 128.4, 116.6, 115.9,
54.6, 47.8, 47.3, 31.7, 25.6. ESI: m/z (%) 242 (M+ + 1); EI-MS: m/z
(%) 241 (M+, 6), 200 (13), 186 (73), 136 (70), 105 (100), 91 (22), 77
(68), 67 (17); HR-MS: calcd for C16H19NO, 241.1466; obsd, 241.1468.
(Rf 0.56, SiO2, 8:2 hexanes/EtOAc) to yield 3h (145 mg, 0.88 mmol,
45%) as a clear oil.
1H NMR (CDCl3, 300 MHz): δ 5.29 (m, 1H), 2.82 (d, J ) 6.4 Hz,
2H), 1.85-1.71 (m, 4H), 1.71 (d, J ) 1.2 Hz, 3H), 1.58 (s, 3H), 1.48-
1.47 (m, 2H), 1.40-1.29 (m, 2H), 1.20-1.08 (m, 2H); 13C NMR
(CDCl3, 75 MHz): δ 132.9, 122.5, 58.8, 38.0, 25.8, 24.6, 20.6, 18.2.
ESI: m/z (%) 166 (M+ + 1).
1
7-Cinnamyl-7-aza-bicyclo[4.1.0]heptane (3d): H NMR (CDCl3,
300 MHz): δ 7.38-7.35 (m, 2H), 7.31-7.26 (m, 2H), 7.19 (m, 1H),
6.56 (d, J ) 15.9 Hz, 1H), 6.29 (dt, J ) 15.8, 5.6 Hz, 1H), 3.00 (dd,
J ) 5.6, 1.5 Hz, 2H), 1.90-1.71 (m, 4H), 1.57-1.53 (m, 2H), 1.44-
1.32 (m, 2H), 1.26-1.12 (m, 2H); 13C NMR (CDCl3, 75 MHz): δ
137.5, 130.8, 128.6, 127.7, 127.3, 126.4, 62.8, 38.3, 24.6, 20.7. ESI:
m/z (%) 214 (M+ + 1, 100), 117 (60); EI-MS: m/z (%) 213 (M+, 24),
117 (46), 96 (100), 69 (54); HR-MS: calcd for C15H19N, 213.1517;
obsd, 213.1511.
7-(1,1-Dimethylallyl)-7-aza-bicyclo[4.1.0]heptane (4h): Clear liq-
1
uid, 89% yield. H NMR (CDCl3, 300 MHz): δ 5.63 (dd, J ) 17.4,
10.7 Hz, 1H), 5.07-5.00 (m, 2H), 1.71-1.66 (m, 4H), 1.41-1.26 (m,
6H), 1.07 (s, 6H); 13C NMR (CDCl3, 75 MHz): δ 143.2, 113.7, 56.6,
34.9, 31.8, 30.2, 25.7, 25.3, 22.9, 20.8, 14.3. ESI: m/z (%) 166 (M+
+
1, 100), 98 (40); EI-MS: m/z (%) 165 (M+, 2), 150 (27), 96 (100), 84
(67), 69 (87); HR-MS: calcd for C11H19N, 165.1517; obsd, 165.1517.
Methyl 1-(3-Methylbut-2-enyl)aziridine-2-carboxylate (3k): 1H
NMR (CDCl3, 300 MHz): δ 5.32 (t, J ) Hz, 1H), 3.72 (s, 3H), 3.03
(dd, J ) 13.2, 6.9 Hz, 1H), 2.91 (dd, J ) 13.2, 6.9 Hz, 1H), 2.16 (d,
J ) 2.8 Hz, 1H), 2.10 (d, J ) 6.4, 2.8 Hz, 1H), 1.62 (d, J ) 6.4 Hz,
1H), 1.73 (s, 3H), 1.61 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ 171.6,
135.5 120.5, 57.9, 52.3, 36.9, 34.3, 25.9, 18.3. EI-MS: m/z (%) 170
(M+ + 1, 1) 168 (1), 154 (31), 110 (61), 83 (23), 69 (100), 55 (29);
HR-MS: calcd for C9H16NO2, 170.1181; obsd, 170.1176.
1
7-(1-Phenylallyl)-7-aza-bicyclo[4.1.0]heptane (4d): H NMR (CDCl3,
300 MHz): δ 7.41-7.36 (m, 2H), 7.33-7.27 (m, 2H), 7.24-7.18 (m,
1H), 5.97 (ddd, J ) 17.0, 10.2, 6.6 Hz, 1H), 5.19 (ddd, J ) 17.1, 1.8,
1.3 Hz, 1H), 5.05 (ddd, J ) 10.2, 1.8, 1.0 Hz, 1H), 2.89 (d, J ) 6.6
Hz, 1H), 1.87-1.53 (m, 6H), 1.49-1.37 (m, 2H), 1.24-1.13 (m, 2H);
13C NMR (CDCl3, 75 MHz): δ 142.5, 140.6, 128.2, 127.4, 126.9, 114.6,
77.2, 38.1, 38.0, 24.7, 24.6, 20.7, 20.6. ESI: m/z (%) 214 (M+ + 1,
100) + 117 (30).
1-Cinnamyl-2-methylaziridine (3e): Clear oil, 84% yield. 1H NMR
(CDCl3, 300 MHz): δ 7.36 (d, J ) 7.0 Hz, 2H), 7.30-7.25 (m, 2H),
7.18 (t, J ) 7.2 Hz, 1H), 6.55 (d, J ) 15.9 Hz, 1H), 6.30 (dt, J ) 16.2,
5.7 Hz, 1H), 2.98 (dddd, J ) 15.0, 14.4, 5.7, 1.5 Hz, 2H), 1.52 (d, J
) 3.7 Hz, 1H), 1.43-1.36 (m, 1H), 1.26 (d, J ) 6.3 Hz 1H), 1.20 (d,
J ) 5.4 Hz, 3H); 13C NMR (CDCl3, 75 MHz): δ 137.2, 131.0, 128.5,
Methyl 1-(2-Methylbut-3-en-2-yl)aziridine-2-carboxylate (4k): 1H
NMR (CDCl3, 300 MHz): δ 5.56 (dd, J ) 17.4, 10.8 Hz, 1H), 5.17
(dd, J ) 10.8, 1.2 Hz, 1H), 5.11 (dd, J ) 17.4, 1.2 Hz, 1H), 3.72 (s,
3H), 2.24 (dd, J ) 6.3, 2.9 Hz, 1H), 1.98 (dd, 2.9, 1.2 Hz, 1H), 1.79
(dd, 6.3, 1.2 Hz, 1H), 1.21 (s, 3H), 1.19 (s, 3H); 13C NMR (CDCl3, 75
MHz): δ 171.9, 139.7, 116.1, 57.0, 52.1, 30.8, 27.7, 25.8, 25.4; ESI:
m/z (%) 170 (M+ + 1, 80), 102 (100); ESI(QStar) calcd for C9H16NO2,
170.1175; obsd, 170.1170.
1-(2-Methylbut-3-en-2-yl)-2-phenylaziridine (4m): Clear oil, 72%
yield. 1H NMR (CDCl3, 300 MHz): δ 7.30-7.22 (m, 4H), 7.20-7.14
(m, 1H), 5.68 (dd, J ) 17.3, 11.1 Hz, 1H), 5.12 (dd, J ) 17.3, 1.5 Hz,
1H), 5.10 (dd, J ) 11.1, 1.5 Hz, 1H), 2.56 (dd, J ) 6.4, 3.1 Hz, 1H),
1.85 (dd, J ) 6.4, 1.0 Hz, 1H), 1.62 (dd, J ) 3.1, 1.0 Hz, 1H), 1.20 (s,
3H), 1.19 (s, 3H); 13C NMR (CDCl3, 75 MHz): δ 141.5, 141.2, 128.3,
126.7, 126.6, 115.0, 56.9, 33.9, 30.5, 26.0, 25.7. ESI: m/z (%) 188
(M+ + 1, 100), 120 (75); EI-MS: m/z (%) 186 (M+ - 1, 2), 146 (8),
118 (94), 91 (100); HR-MS: calcd for C13H16N, 186.1282; obsd,
186.1286.
(E)-7-(3,7-Dimethylocta-2,6-dienyl)-7-aza-bicyclo[4.1.0]heptane
(3n): 1H NMR (CDCl3, 300 MHz): δ 5.33-5.29 (m, 1H), 5.08-5.13
(m, 1H), 2.85 (d, J ) 6.3 Hz, 2H), 2.17-1.99 (m, 4H), 1.85-1.72 (m,
4H), 1.68 (s, 3H), 1.61 (s, 3H), 1.57 (s, 3H), 1.50-1.49 (m, 2H), 1.40-
1.26 (m, 2H), 1.20-1.09 (m, 2H); 13C NMR (CDCl3, 75 MHz): δ
136.7, 131.6, 124.4, 122.4, 58.8, 39.8, 38.2, 26.7, 25.9, 24.8, 20.8, 17.9,
16.8. ESI: m/z (%) 234 (M+ + 1, 100), 98 (8); EI-MS: m/z (%) 233
(M+, 3), 218 (5), 190 (3), 164 (8), 150 (8), 136 (6), 121 (4), 110 (11),
96 (100), 81 (14), 69 (39), 55 (7); HR-MS: calcd for C16H27N,
233.2143; obsd, 233.2147.
7-(3,7-Dimethylocta-1,6-dien-3-yl)-7-aza-bicyclo[4.1.0]heptane
(4n): 1H NMR (CDCl3, 300 MHz): δ 5.55 (dd, J ) 11.0, 17.6 Hz,
1H), 5.15-5.09 (m, 1H), 5.09 (dd, J ) 1.8, 11.0 Hz, 1H), 5.03 (dd, J
) 1.8, 17.6 Hz, 1H), 2.08-1.99 (m, 4H), 1.70-1.65 (m, 7H), 1.60 (s,
3H), 1.52-1.43 (m, 2H), 1.43-1.34 (m, 2H), 1.19-1.06 (m, 2H), 0.98
(s, 3H); 13C NMR (CDCl3, 75 MHz): δ 141.5, 131.2, 125.4, 115.1,
59.2, 41.8, 30.1, 29.7, 25.9, 25.3, 25.2, 23.1, 21.3, 20.9, 20.8, 17.8.
ESI: m/z (%) 234 (M+ + 1, 100), 98 (20); EI-MS: m/z (%) 233 (M+,
11), 218 (12), 190 (27), 164 (11), 150 (100), 136 (29), 121 (18), 108
(24), 96 (93), 81 (45), 69 (82), 55 (27); HR-MS: calcd for C16H27N,
233.2143; obsd, 233.2149.
127.3, 127.2, 126.3, 62.7, 34.6, 34.4, 18.4. ESI: m/z (%) 174 (M+
+
1, 30), 117 (100); EI-MS: m/z (%) 173 (M+, 18), 130 (15), 117 (68),
104 (18), 91 (32), 77 (13), 56 (100); HR-MS: calcd for C12H15N,
173.1204; obsd, 173.1206.
Methyl 1-Cinnamylaziridine-2-carboxylate (3f): Clear oil, 88%
yield. 1H NMR (CDCl3, 300 MHz): δ 7.37 (d, J ) 7.5 Hz, 1H), 7.31
(t, J ) 7.5 Hz, 2H), 7.23 (t, J ) 7.3 Hz, 1H), 6.54 (d, J ) 16.1 Hz,
1H), 6.31 (dt, J ) 16.1, 6.0 Hz, 1H), 3.73 (s, 3H), 3.19 (ddd, J ) 13.7,
6.0, 1.3 Hz, 1H), 3.06 (ddd, J ) 13.7, 6.0, 1.3 Hz, 1H), 2.23 (d, J )
3.3 Hz, 1H), 2.17 (dd, J ) 6.4, 3.3 Hz, 1H), 1.69 (d, J ) 6.4 Hz, 1H);
13C NMR (CDCl3, 75 MHz): δ 171.3, 136.8, 132.6, 128.7, 127.8, 126.5,
125.7, 62.4, 52.4, 37.3, 34.5. ESI: m/z (%) 218 (M+ + 1, 20), 117
(100); EI-MS: m/z (%) 217 (M+, 7), 158 (59), 130 (74), 117 (100), 91
(42); HR-MS: calcd for C13H15NO2, 217.1102; obsd, 217.1101.
(E)-Methyl 1-(2-(Methoxycarbonyl)-3-phenylallyl)aziridine-2-car-
boxylate (3g): Clear oil, 84% yield. Compound isolated as an
inseparable mix of regioisomers. Major regioisomer: 1H NMR (CDCl3,
300 MHz): δ 7.89 (s, 1H), 7.67 (d, J ) 7.5 Hz, 2H), 7.42-7.35 (m,
3H), 3.83 (s, 3H), 3.71 (s, 3H), 3.42 (d, J ) 12.3 Hz, 2H), 3.29 (d, J
) 12.3 Hz, 2H), 2.41 (m, 1H), 2.22 (m, 1H), 1.95 (d, J ) 6.4 Hz, 1H);
13C NMR (CDCl3, 75 MHz): δ 171.3, 168.3, 143.8, 134.8, 130.1, 129.2,
128.5, 72.2, 55.0, 52.1, 52.0, 37.1, 34.8. Minor regioisomer, mix of
diasteriomers: 1H NMR (CDCl3, 300 MHz): δ 7.34-7.23 (m, 1H),
6.40 (s, 0.2H), 6.32 (s, 0.2H), 3.66 (s, 0.6H), 3.62 (s, 0.6H), 2.32 (m,
0.2H), 2.26-2.24 (m, 0.2H), 1.82 (d, 0.2H); 13C NMR (CDCl3, 75
MHz): δ 170.8, 166.4, 141.3, 140.0, 128.4, 127.7, 127.7, 126.5, 60.3,
51.8, 37.2, 35.4, 20.9, 14.2. ESI: m/z (%) 276 (M+ + 1, 100), 175
(80); EI-MS: m/z (%) 275 (M+, 9), 244 (12), 216 (92), 188 (100), 156
(20), 115 (85); HR-MS: calcd for C15H17NO4, 275.1157; obsd,
275.1150.
7-(3-Methylbut-2-enyl)-7-aza-bicyclo[4.1.0]heptane (3h): In a
flame-dried 50-mL one-neck round-bottom flask, equipped with
magnetic stir bar and septum, were placed 1a (200 µL, 1.95 mmol),
K2CO3 (540 mg, 3.90 mmol), and dry acetone (20 mL). Prenyl bromide
(227 µL, 1.95 mmol) was slowly added to the solution via syringe at
room temperature. The resulting solution was stirred under a stream
of nitrogen at room temperature for 30 min, when GC analysis showed
no remaining cyclohexene imine (1a). Solvent was removed in vacuo,
and the resultant yellow oil was purified by flash chromatography
7-(1,3-Diphenylallyl)-7-aza-bicyclo[4.1.0]heptane (3p): White solid,
97% yield (mp of racemate ) 79.5-81.0 °C), 97% ee as measured by
HPLC (AD column, 1 mL/min, 99:1 hexanes/i-PrOH, t ) 4.5 and 5.0
min. 97% ee - 4.5 min enantiomer, using (R)-BINAP). 1H NMR
(CDCl3, 300 MHz): δ 7.45 (d, J ) 6.9 Hz, 2H), 7.39-7.17 (m, 8H),
9
17528 J. AM. CHEM. SOC. VOL. 127, NO. 49, 2005